Skip to content
Sharma East India Hosp and Medical Research logo

Sharma East India Hosp and Medical Research

524548 BSE
Price unavailable

Sharma East India Hosp and Medical Research (SHARMEH) share price was ₹80.48 at the 27 Oct 2026 close; market capitalisation ₹26.43 Cr; P/E (TTM) 22.36; sector Healthcare Services. The share price fell 45.3% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 13.6% year on year to ₹10.76 Cr and net profit was ₹0.26 Cr, against ₹0.32 Cr a year earlier (compared with Jun 2025). Promoters held 53.63% of Sharma East India Hosp and Medical Research in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 39/100 (Weak) as of 28 Oct 2026.

Close 27 Oct 2026 ₹80.48 −67.07 −45.46% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹26.43 Cr
P/E (TTM)
22.36
EBITDA
₹3.80 Cr
Return on Equity
9.06%
Debt to Equity
0.53
Book Value
₹39.15
EPS (TTM)
₹3.60
52W High
₹154.00
52W Low
₹79.00

Price-based figures as of 27 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,905.4058.9231,982 Cr12.750.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,438.9078.9314,820 Cr15.480.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.1056.4311,388 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹514.6546.458,191 Cr15.982.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹318.3546.271,658 Cr6.770.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹496.0516.271,609 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Sharma East India Hosp and Medical Research (this company)
—22.3626 Cr2.060.00%9.06%14.24%37 Cr1 Cr
Median 8 companies₹549.1051.447,265 Cr7.180.21%12.72%15.22%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

39 Weak
Overall score

Data confidence 100/100

Category scores

Quality Poor 24
Returns, margins, earnings quality 22% weight
Valuation Weak 43
Cheap vs sector & own history 24% weight
Growth Good 57
Sales & profit trajectory 9% weight
Financial Health Poor 31
Solvency, leverage, coverage 9% weight
Momentum Poor 25
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

2
  • Company has a low return on equity of -5.75% over last 3 years.
  • Debtor days have increased from 82.3 to 116 days.

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
12
Neutral
4
Bullish
3

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
19.54% lower than 3Y

change over 1 year

Net Income Growth
0% lower than 3Y

change over 1 year

Cash Flow Change
-158%

change over 1 year

EBITDA Margin Change
-20.02%

change over 1 year Operating margin 7.99% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
5.51
5.36
5.85
1.8
6.72
9.02
8.15
5.98
9.47
9.38
9.61
7.47
10.76
Expenses
4.69
4.62
4.95
6.13
5.86
7.91
7.29
5.17
8.55
8.44
8.85
6.46
9.9
Operating Profit
0.82
0.74
0.9
-4.33
0.86
1.11
0.86
0.81
0.92
0.94
0.76
1.01
0.86
OPM %
14.88%
13.81%
15.38%
-240.56%
12.8%
12.31%
10.55%
13.55%
9.71%
10.02%
7.91%
13.52%
7.99%
Other Income
0
0
0
5.31
0
0.04
0.04
0.23
0.04
0.05
0.05
0.02
0.04
Interest
0.28
0.22
0.31
0.14
0.17
0.25
0.15
0.14
0.11
0.1
0.13
0.16
0.19
Depreciation
0.34
0.34
0.35
0.46
0.35
0.44
0.36
0.67
0.42
0.43
0.43
0.44
0.36
PBT
0.2
0.18
0.24
0.38
0.34
0.46
0.39
0.23
0.43
0.46
0.25
0.43
0.35
Tax %
55%
-61.11%
0%
89.47%
26.47%
26.09%
25.64%
-60.87%
25.58%
28.26%
28%
0%
25.71%
Net Profit
0.1
0.29
0.23
0.04
0.25
0.34
0.29
0.37
0.32
0.32
0.18
0.43
0.26
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
16.36
17.21
17.14
16
14.73
16.17
8.13
17.04
20.73
18.52
29.87
35.93
37.22
Expenses
15.11
16.33
15.51
14.54
14.09
14.24
8.79
14.79
17.43
20.4
26.21
32.3
33.65
Operating Profit
1.25
0.88
1.63
1.46
0.64
1.93
-0.66
2.25
3.3
-1.88
3.66
3.63
3.57
OPM %
7.64%
5.11%
9.51%
9.12%
4.34%
11.94%
-8.12%
13.2%
15.92%
-10.15%
12.25%
10.1%
9.59%
Other Income
0.55
0.22
0.26
0.07
1.11
0.03
2.83
0.06
0.06
5.31
0.31
0.16
0.16
Interest
0.76
0.48
1.08
0.73
0.88
1.15
0.69
0.7
1.18
0.95
0.72
0.51
0.58
Depreciation
0.61
0.59
0.7
0.62
0.52
0.43
0.65
0.78
1.39
1.48
1.84
1.72
1.66
PBT
0.43
0.03
0.11
0.18
0.35
0.38
0.83
0.83
0.79
1
1.41
1.56
1.49
Tax %
-30.23%
33.33%
27.27%
27.78%
22.86%
18.42%
24.1%
18.07%
-5.06%
34%
12.06%
20.51%
—
Net Profit
0.57
0.03
0.08
0.13
0.27
0.31
0.64
0.68
0.83
0.66
1.24
1.24
1.19
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.16
4.16
4.16
4.16
4.16
4.16
4.16
4.16
4.16
4.16
4.16
4.16
Reserves
2.03
2.05
3.32
3.46
3.73
4.12
4.76
5.44
6.41
7.07
8.32
9.56
Borrowings
5.97
6.47
7.51
5.38
10.89
7.42
5.98
4.35
8.3
5.04
2.26
7.29
Other Liabilities
2.36
2.68
2.65
3.28
3.35
4.16
3.98
5.11
4.84
8.89
12.94
11.91
Total Liabilities
14.52
15.36
17.64
16.28
22.13
19.86
18.88
19.06
23.71
25.16
27.68
32.92
Fixed Assets
6.58
6.01
6.4
6.07
4.73
4.41
5.51
6.85
9.1
7.7
9.37
8.45
CWIP
0
0
0
0.01
0.35
1.74
0
0
0
0
0
0
Investments
0.31
0.31
1.79
1.79
1.8
1.89
1.89
1.89
2.05
2.05
2.05
2.05
Other Assets
7.63
9.04
9.45
8.41
15.25
11.82
11.48
10.32
12.56
15.41
16.26
22.42
Total Assets
14.52
15.36
17.64
16.28
22.13
19.86
18.88
19.06
23.71
25.16
27.68
32.92
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.2
-0.14
0.82
3.12
-1.43
1.21
1.4
2.03
1.28
-1.13
6.69
-3.86
Investing
-0.02
-0.01
-0.77
-0.25
1.65
-1.5
2.79
-2.11
-3.63
5.17
-3.26
-0.65
Financing
-0.81
0.19
-0.08
-2.8
4.74
-4.74
-2.16
-1.78
2.77
-4.2
-3.5
4.52
Net Cash Flow
-1.03
0.05
-0.03
0.06
4.96
-5.03
2.03
-1.86
0.41
-0.17
-0.06
0.01
Free Cash Flow
-0.7
-0.68
0.05
2.86
0.22
-0.29
4.19
-0.09
-2.36
4.01
3.35
-4.66
CFO/OP
-6
-14
53
218
-212
66
-232
96
39
45
189
-95
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
46.63
57.69
49.4
74.14
85.49
107
120
72.61
75.54
50.85
79.92
116
Inventory Days
16.83
73.23
—
98.98
—
—
217
49.38
41.71
226
211
131
Days Payable
138
121
—
144
—
—
481
391
305
1,659
418
165
Cash Conversion Cycle
-75.04
10.37
49.4
29.29
85.49
107
-144
-269
-188
-1,383
-127
81.96
Working Capital Days
100
27.15
20.87
18.71
-75.08
46.5
48.04
35.99
-2.64
-116
2.69
15.64
ROCE %
8.93%
4.11%
8.6%
6.5%
1.57%
8.87%
-8.3%
10.61%
12%
-18.61%
12.77%
11.58%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sharma East India Hosp and Medical Research insights

58 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Promot.53.63%Others14.07%Public32.30%As ofSep 2026

Documents

Frequently Asked Questions about Sharma East India Hosp and Medical Research

What does Sharma East India Hosp and Medical Research Ltd do?
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]
Where is Sharma East India Hosp and Medical Research Ltd (SHARMEH) listed?
Sharma East India Hosp and Medical Research Ltd trades under code 524548 on the BSE.
Which sector does Sharma East India Hosp and Medical Research Ltd belong to?
Sharma East India Hosp and Medical Research Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Sharma East India Hosp and Medical Research Ltd?
Sharma East India Hosp and Medical Research Ltd has a market capitalisation of ₹26.43 Cr as of 27 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Sharma East India Hosp and Medical Research Ltd?
Sharma East India Hosp and Medical Research Ltd trades at a PE ratio of 22.36 as of 27 Oct 2026, on earnings per share of ₹3.6, against a book value of ₹39.15 per share.
What is the 52-week high and low of Sharma East India Hosp and Medical Research Ltd?
Over the last 52 weeks Sharma East India Hosp and Medical Research Ltd has traded between ₹79 and ₹154 as of 27 Oct 2026.
What is the Return on Equity (ROE) of Sharma East India Hosp and Medical Research Ltd?
Sharma East India Hosp and Medical Research Ltd reported a return on equity of 9.06%. Its debt-to-equity ratio is 0.53.

Company Information

Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]

Website jaipurhospital.co.in
Listed 2024-07-04
Face Value ₹ 10
Shares Outstanding 32,83,951

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524548.md for Sharma East India Hosp and Medical Research Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month